CIBC Private Wealth Group
NGNE icon

CIBC Private Wealth Group’s Neurogene NGNE Stock Holding History

CIBC Private Wealth Group’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9,421
Closed -$2.66M – 1042
2020
Q4 		$2.66M Buy
+9,421
New +$2.3M 0.01% 456

Other funds holding NGNE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

CIBC Private Wealth Group's NGNE Position: Q1 2021 in Review

CIBC Private Wealth Group sold out of Neurogene (NGNE) in Q1 2021, closing a stake of 9,421 shares — an estimated $2.66M sold.

CIBC Private Wealth Group first reported a position in NGNE in Q4 2020 and held it in 1 quarter. The position peaked at $2.66M in Q4 2020. 82 funds tracked by Wall St. Rank hold NGNE as of Q1 2021.

  • CIBC Private Wealth Group reported no remaining Neurogene position as of Q1 2021 after selling out during the quarter.
  • CIBC Private Wealth Group sold 9,421 Neurogene shares in Q1 2021, an estimated $2.66M.
  • CIBC Private Wealth Group first reported a position in Neurogene in Q4 2020 and held it in 1 quarter.
  • CIBC Private Wealth Group's Neurogene position peaked at $2.66M in Q4 2020.
  • 82 funds tracked by Wall St. Rank held Neurogene as of Q1 2021.

Based on CIBC Private Wealth Group's 13F filing for Q1 2021, filed 12 May 2021.